top
Search terms
Results 1 - 10 of 46 - ordered by :
Pages: 1 2 3 4 5 ... 5
Escardio

Prof. Mills says, “The trial found that implementation of a high-sensitivity cTnl using the 99th centile as the diagnostic threshold increased the frequency of patients with myocardial injury; ...

Date : 29/08/2018
Escardio

In the phase IIB study, serelaxin was safe and well tolerated, with positive clinical outcome symptoms and signals in patients with acute heart failure. There was, however, an improvement in ...

Date : 28/04/2017
Escardio

[...]most important, it can effectively treat the first and second VT or VF, thus saving the patient from sudden cardiac death and making him able to withstand more arrhythmic episodes.” The ...

Date : 26/08/2012
Escardio

Previous research has shown that psychosocial factors have a stronger detrimental effect on individuals with pre-existing cardiovascular risks than on healthy people. Compared to those with no work ...

Date : 28/04/2019
Escardio

AMSTERDAM, The Netherlands – Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the ...

Date : 02/09/2013
Escardio

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 21/10/2015
Escardio

Gothenburg, Sweden: Two trials presented at the Heart Failure Congress 2011,   organized by the Heart Failure Association of the European Society of Cardiology (HFA of the ESC), will help to define ...

Date : 22/05/2011
Escardio

Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial ...

Date : 27/08/2017
Escardio

Results were also presented from VIVIDD, the first trial of the anti-diabetes drug vildagliptin in patients with heart failure. The Heart Failure Congress is the main annual meeting of the Heart ...

Date : 26/05/2013
Escardio

Data accumulated over the last 10 years strongly suggests that the risk of HF increases with the severity of abnormality of blood glucose, with an approximately linear relation between metabolic ...

Date : 02/05/2018